For example, Saxenda (liraglutide), which has the same active drug as Victoza, is used for weight loss in people with ... The following chart lists examples of mild side effects that can most ...

The company develops a long line of blockbuster glucagon-like peptide-1 (GLP-1) agonists, including Ozempic, Wegovy, Rybelsus, and Saxenda ... and beyond the weight loss landscape.

Novo Nordisk remains a sell due to increased competition and regulatory risks, despite its leadership in the diabetes and weight-loss markets ... drugs Victoza and Saxenda, which were labeled ...

Allurion Technologies has presented data from two studies showing the efficacy of its swallowable gastric balloon in causing significant weight loss. One study evaluated the device in patients who ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy and Saxenda more than doubled, a study published Friday found.

Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.